LabGenius

Accelerating antibody discovery with machine intelligence.

LabGenius harnesses the power of artificial intelligence and robotics to accelerate the discovery of innovative therapeutic antibodies. By leveraging a smart robotic platform called EVA, they design, conduct, and learn from experiments to identify high-performing antibodies faster than traditional methods. This approach enables the rapid discovery and optimization of novel antibody therapeutics for various diseases, including cancer and inflammatory conditions. With LabGenius, clients can tap into a multidisciplinary team of experts in computer science, robotic automation, and synthetic biology, ensuring that their protein engineering problems are solved efficiently. By partnering with LabGenius, companies can access cutting-edge technology and expertise to develop innovative therapies.